Scaling Cell Therapies to Enable Large Scale Manufacturing & Market Readiness

• Leveraging bioreactors to achieve commercial scale
• Comparing with alternative scale-up methods to identify trade-offs in efficiency, control and product quality
• Analyzing cell phenotype post-scale-up to understand the impact of use on product quality

Speakers:

Justin Skoble

Vice President - Technical Operations

Caribou Biosciences